TY - JOUR
T1 - DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia
AU - Garcia-Manero, Guillermo
AU - Daniel, Jerry
AU - Smith, Terry L.
AU - Kornblau, Steven M.
AU - Lee, Ming Sheng
AU - Kantarjian, Hagop M.
AU - Issa, Jean Pierre J.
PY - 2002
Y1 - 2002
N2 - Purpose: Aberrant methylation of promoter-associated CpG islands is an epigenetic oncogenic mechanism. The objective of this study was to define the methylation characteristics of patients with acute lymphocytic leukemia (ALL). Experimental Design: Using bisulfite-PCR followed by restriction enzyme digestion (COBRA), we have analyzed the methylation status of 10 promoter-associated CpG islands in 80 untreated adult patients with ALL. Results: Mean methylation density of MDR1, THBS2, MYF3, ER, p15, THBS1, CD10, C-ABL, and p16 was 24.5%, 20.8%, 17.6%, 16.1%, 11.3%, 8.9%, 4.5%, 3.7%, and 1.3% respectively. p73 was methylated in 17 of 80 cases (21.2%). A total of 86.2% of the cases had methylation of at least one gene, and 42.5% of the cases had methylation of three or more genes. MDR1 methylation was inversely correlated with age (P = 0.01). CD10 methylation inversely correlated with CD10 expression (P = 0.0001). Methylation of MDR1 and THBS1 was inversely associated with the presence of the Philadelphia chromosome, whereas C-ABL methylation correlated with the presence of the p210 variant of the Philadelphia chromosome. In univariate analysis, methylation of THBS1 was associated with a favorable outcome (P = 0.02), whereas methylation of p73, p15, and C-ABL was associated with a trend toward worse prognosis. Conclusions: Aberrant DNA methylation of promoter associated CpG islands is very common in adult ALL and potentially defines subgroups with distinct clinical and biological characteristics.
AB - Purpose: Aberrant methylation of promoter-associated CpG islands is an epigenetic oncogenic mechanism. The objective of this study was to define the methylation characteristics of patients with acute lymphocytic leukemia (ALL). Experimental Design: Using bisulfite-PCR followed by restriction enzyme digestion (COBRA), we have analyzed the methylation status of 10 promoter-associated CpG islands in 80 untreated adult patients with ALL. Results: Mean methylation density of MDR1, THBS2, MYF3, ER, p15, THBS1, CD10, C-ABL, and p16 was 24.5%, 20.8%, 17.6%, 16.1%, 11.3%, 8.9%, 4.5%, 3.7%, and 1.3% respectively. p73 was methylated in 17 of 80 cases (21.2%). A total of 86.2% of the cases had methylation of at least one gene, and 42.5% of the cases had methylation of three or more genes. MDR1 methylation was inversely correlated with age (P = 0.01). CD10 methylation inversely correlated with CD10 expression (P = 0.0001). Methylation of MDR1 and THBS1 was inversely associated with the presence of the Philadelphia chromosome, whereas C-ABL methylation correlated with the presence of the p210 variant of the Philadelphia chromosome. In univariate analysis, methylation of THBS1 was associated with a favorable outcome (P = 0.02), whereas methylation of p73, p15, and C-ABL was associated with a trend toward worse prognosis. Conclusions: Aberrant DNA methylation of promoter associated CpG islands is very common in adult ALL and potentially defines subgroups with distinct clinical and biological characteristics.
UR - http://www.scopus.com/inward/record.url?scp=0035992430&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035992430&partnerID=8YFLogxK
M3 - Article
C2 - 12114423
AN - SCOPUS:0035992430
SN - 1078-0432
VL - 8
SP - 2217
EP - 2224
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 7
ER -